Optimization of Tyrosine Kinase Inhibitor-Loaded Gold Nanoparticles for Stimuli-Triggered Antileukemic Drug Release.

J Funct Biomater · 2023 · PMC10455807 · PMID 37623644

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Thus, it is a highly significant target for TKI-based AML therapy and multiple TKIs have been investigated for this purpose, such as Sunitinib, Sorafenib, Lestaurtinib, Midostaurin, Crenolanib, and Quizartinib [ 11 , 12 , 13 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.